The impact of anxiety on gait impairments in Parkinson's disease: insights from sensor-based gait analysis.
Anxiety
Gait analysis
Parkinson’s disease
Treatment
Wearable sensors
Journal
Journal of neuroengineering and rehabilitation
ISSN: 1743-0003
Titre abrégé: J Neuroeng Rehabil
Pays: England
ID NLM: 101232233
Informations de publication
Date de publication:
30 Apr 2024
30 Apr 2024
Historique:
received:
12
07
2023
accepted:
22
04
2024
medline:
1
5
2024
pubmed:
1
5
2024
entrez:
30
4
2024
Statut:
epublish
Résumé
Sensor-based gait analysis provides a robust quantitative tool for assessing gait impairments and their associated factors in Parkinson's disease (PD). Anxiety is observed to interfere with gait clinically, but this has been poorly investigated. Our purpose is to utilize gait analysis to uncover the effect of anxiety on gait in patients with PD. We enrolled 38 and 106 PD patients with and without anxiety, respectively. Gait parameters were quantitively examined and compared between two groups both in single-task (ST) and dual-task (DT) walking tests. Multiple linear regression was applied to evaluate whether anxiety independently contributed to gait impairments. During ST, PD patients with anxiety presented significantly shorter stride length, lower gait velocity, longer stride time and stance time, longer stance phase, smaller toe-off (TO) and heel-strike (HS) angles than those without anxiety. While under DT status, the differences were diminished. Multiple linear regression analysis demonstrated that anxiety was an independent factor to a serials of gait parameters, particularly ST-TO (B = -2.599, (-4.82, -0.38)), ST-HS (B = -2.532, (-4.71, -0.35)), ST-TO-CV (B = 4.627, (1.71, 7.64)), ST-HS-CV(B = 4.597, (1.66, 7.53)), ST stance phase (B = 1.4, (0.22, 2.58)), and DT stance phase (B = 1.749, (0.56, 2.94)). Our study discovered that anxiety has a significant impact on gait impairments in PD patients, especially exacerbating shuffling steps and prolonging stance phase. These findings highlight the importance of addressing anxiety in PD precision therapy to achieve better treatment outcomes.
Sections du résumé
BACKGROUND
BACKGROUND
Sensor-based gait analysis provides a robust quantitative tool for assessing gait impairments and their associated factors in Parkinson's disease (PD). Anxiety is observed to interfere with gait clinically, but this has been poorly investigated. Our purpose is to utilize gait analysis to uncover the effect of anxiety on gait in patients with PD.
METHODS
METHODS
We enrolled 38 and 106 PD patients with and without anxiety, respectively. Gait parameters were quantitively examined and compared between two groups both in single-task (ST) and dual-task (DT) walking tests. Multiple linear regression was applied to evaluate whether anxiety independently contributed to gait impairments.
RESULTS
RESULTS
During ST, PD patients with anxiety presented significantly shorter stride length, lower gait velocity, longer stride time and stance time, longer stance phase, smaller toe-off (TO) and heel-strike (HS) angles than those without anxiety. While under DT status, the differences were diminished. Multiple linear regression analysis demonstrated that anxiety was an independent factor to a serials of gait parameters, particularly ST-TO (B = -2.599, (-4.82, -0.38)), ST-HS (B = -2.532, (-4.71, -0.35)), ST-TO-CV (B = 4.627, (1.71, 7.64)), ST-HS-CV(B = 4.597, (1.66, 7.53)), ST stance phase (B = 1.4, (0.22, 2.58)), and DT stance phase (B = 1.749, (0.56, 2.94)).
CONCLUSION
CONCLUSIONS
Our study discovered that anxiety has a significant impact on gait impairments in PD patients, especially exacerbating shuffling steps and prolonging stance phase. These findings highlight the importance of addressing anxiety in PD precision therapy to achieve better treatment outcomes.
Identifiants
pubmed: 38689288
doi: 10.1186/s12984-024-01364-3
pii: 10.1186/s12984-024-01364-3
doi:
Types de publication
Journal Article
Research Support, Non-U.S. Gov't
Langues
eng
Sous-ensembles de citation
IM
Pagination
68Subventions
Organisme : Zhejiang Provincial Public Service and Application Research Foundation
ID : LGF21H090009
Organisme : Zhejiang Provincial Public Service and Application Research Foundation
ID : LGF20H090007
Organisme : Medical Scientific Research Foundation of Zhejiang Province
ID : 2023KY271
Organisme : Ningbo Medical Key Discipline
ID : 2022-B12
Organisme : Hwa Mei Foundation
ID : 2019HMKY27
Informations de copyright
© 2024. The Author(s).
Références
Parkinson’s disease statistics,Parkinson’s Foundation. https://www.parkinson.org/Understanding-Parkinsons/Statistics 2023 [ Accessed on 11/12/2023].
Bloem BR, Okun MS, Klein C. Parkinson’s disease. Lancet. 2021;397:2284–303.
doi: 10.1016/S0140-6736(21)00218-X
pubmed: 33848468
Mirelman A, Bonato P, Camicioli R, et al. Gait impairments in Parkinson’s disease. Lancet Neurol. 2019;18:697–708.
doi: 10.1016/S1474-4422(19)30044-4
pubmed: 30975519
Zhang WS, Gao C, Tan YY, et al. Prevalence of freezing of gait in Parkinson’s disease: a systematic review and meta-analysis. J Neurol. 2021;268:4138–50.
doi: 10.1007/s00415-021-10685-5
pubmed: 34236501
Hiorth YH, Alves G, Larsen JP, et al. Long-term risk of falls in an incident Parkinson’s disease cohort: the Norwegian ParkWest study. J Neurol. 2017;264:364–72.
doi: 10.1007/s00415-016-8365-z
pubmed: 28000003
Soh SE, Morris ME, McGinley JL. Determinants of health-related quality of life in Parkinson’s disease: a systematic review. Parkinsonism Relat Disord. 2011;17:1–9.
doi: 10.1016/j.parkreldis.2010.08.012
pubmed: 20833572
Dissanayaka NN, Sellbach A, Matheson S, et al. Anxiety disorders in Parkinson’s disease: prevalence and risk factors. Mov Disord. 2010;25:838–45.
doi: 10.1002/mds.22833
pubmed: 20461800
Pimenta M, Moreira D, Nogueira T, et al. Anxiety independently contributes to severity of freezing of Gait in People with Parkinson’s Disease. J Neuropsychiatry Clin Neurosci. 2019;31:80–5.
doi: 10.1176/appi.neuropsych.17090177
pubmed: 30187821
Del Din S, Elshehabi M, Galna B, et al. Gait analysis with wearables predicts conversion to parkinson disease. Ann Neurol. 2019;86:357–67.
doi: 10.1002/ana.25548
pubmed: 31294853
pmcid: 6899833
Gassner H, Raccagni C, Eskofier BM, et al. The diagnostic scope of Sensor-based gait analysis in atypical parkinsonism: further observations. Front Neurol. 2019;10:5.
doi: 10.3389/fneur.2019.00005
pubmed: 30723450
pmcid: 6349719
Mico-Amigo ME, Kingma I, Heinzel S, et al. Potential markers of Progression in Idiopathic Parkinson’s Disease Derived from Assessment of Circular Gait with a single body-Fixed-Sensor: a 5 year longitudinal study. Front Hum Neurosci. 2019;13:59.
doi: 10.3389/fnhum.2019.00059
pubmed: 30837857
pmcid: 6389786
Curtze C, Nutt JG, Carlson-Kuhta P, et al. Levodopa is a double-edged Sword for Balance and Gait in People with Parkinson’s Disease. Mov Disord. 2015;30:1361–70.
doi: 10.1002/mds.26269
pubmed: 26095928
pmcid: 4755510
Gordt K, Gerhardy T, Najafi B, et al. Effects of Wearable Sensor-based balance and gait training on Balance, Gait, and functional performance in healthy and patient populations: a systematic review and Meta-analysis of Randomized controlled trials. Gerontology. 2018;64:74–89.
doi: 10.1159/000481454
pubmed: 29130977
Postuma RB, Berg D, Stern M, et al. MDS clinical diagnostic criteria for Parkinson’s disease. Mov Disord. 2015;30:1591–601.
doi: 10.1002/mds.26424
pubmed: 26474316
Zhang XD, Fan W, Yu H et al. Single- and dual-task gait performance and their diagnostic value in early-stage Parkinson’s disease. Front Neurol 2022;13.
Galna B, Lord S, Rochester L. Is gait variability reliable in older adults and Parkinson’s disease? Towards an optimal testing protocol. Gait Posture. 2013;37:580–5.
doi: 10.1016/j.gaitpost.2012.09.025
pubmed: 23103242
Serrao M, Chini G, Caramanico G, et al. Prediction of responsiveness of Gait Variables to Rehabilitation Training in Parkinson’s Disease. Front Neurol. 2019;10:826.
doi: 10.3389/fneur.2019.00826
pubmed: 31428039
pmcid: 6688512
Ehgoetz Martens KA, Ellard CG, Almeida QJ. Virtually-induced threat in Parkinson’s: dopaminergic interactions between anxiety and sensory-perceptual processing while walking. Neuropsychologia. 2015;79:322–31.
doi: 10.1016/j.neuropsychologia.2015.05.015
pubmed: 26004056
Quek DYL, Economou K, MacDougall H, et al. The influence of visual feedback on alleviating freezing of gait in Parkinson’s disease is reduced by anxiety. Gait Posture. 2022;95:70–5.
doi: 10.1016/j.gaitpost.2022.04.007
pubmed: 35453086
Tosserams A, Bloem BR, Martens KE et al. Modulating arousal to overcome gait impairments in Parkinson’s disease: how the noradrenergic system may act as a double-edged sword. Translational Neurodegeneration 2023;12.
Taylor NL, Wainstein G, Quek D, et al. The contribution of noradrenergic activity to Anxiety-Induced Freezing of Gait. Mov Disord. 2022;37:1432–43.
doi: 10.1002/mds.28999
pubmed: 35384055
pmcid: 9540856
Micó-Amigo ME, Kingma I, Heinzel S et al. Dual vs. Single Tasking During Circular Walking: What Better Reflects Progression in Parkinson’s Disease? Front Neurol 2019;10.
Ehgoetz Martens KA, Silveira CRA, Intzandt BN, et al. Overload from anxiety: a Non-motor cause for Gait impairments in Parkinson’s Disease. J Neuropsychiatry Clin Neurosci. 2018;30:77–80.
doi: 10.1176/appi.neuropsych.16110298
pubmed: 28712343
Mico-Amigo ME, Kingma I, Faber GS, et al. Is the Assessment of 5 Meters of Gait with a single body-fixed-Sensor Enough to recognize idiopathic Parkinson’s Disease-Associated Gait? Ann Biomed Eng. 2017;45:1266–78.
doi: 10.1007/s10439-017-1794-8
pubmed: 28108943
pmcid: 5397518
Witt I, Ganjavi H, MacDonald P. Relationship between Freezing of Gait and Anxiety in Parkinson’s Disease Patients: A Systemic Literature Review. Parkinsons Dis-Us 2019;2019.
Russo M, Amboni M, Volzone A et al. Interplay between gait and neuropsychiatric symptoms in Parkinson’s Disease. Eur J Transl Myol 2022;32.
Sawada H, Umemura A, Kohsaka M, et al. Pharmacological interventions for anxiety in Parkinson’s disease sufferers. Expert Opin Pharmaco. 2018;19:1071–6.
doi: 10.1080/14656566.2018.1485650
Hong CT, Tan S, Huang TW. Psychotherapy for the treatment of anxiety and depression in patients with Parkinson Disease: a Meta-analysis of Randomized controlled trials. J Am Med Dir Assoc. 2021;22:2289–95. e2.
doi: 10.1016/j.jamda.2021.03.031
pubmed: 33957132
Horne JT, Soh D, Cordato DJ, et al. Functional outcomes of an integrated Parkinson’s Disease Wellbeing Program. Australas J Ageing. 2020;39:E94–102.
doi: 10.1111/ajag.12705
pubmed: 31347232
Burt J, Ravid E, Bradford S, et al. The effects of Music-Contingent Gait Training on Cognition and Mood in Parkinson Disease: a feasibility study. Neurorehab Neural re. 2020;34:82–92.
doi: 10.1177/1545968319893303
Lin HW, Tam KW, Kuan YC. Mindfulness or meditation therapy for Parkinson’s disease: A systematic review and meta-analysis of randomized controlled trials. Eur J Neurol 2023.
Kwok JYY, Kwan JCY, Auyeung M, et al. Effects of Mindfulness yoga vs stretching and resistance training exercises on anxiety and depression for people with Parkinson Disease: a Randomized Clinical Trial. JAMA Neurol. 2019;76:755–63.
doi: 10.1001/jamaneurol.2019.0534
pubmed: 30958514
pmcid: 6583059